Common Contracts
44 similar null contracts by Baltic Trading LTD, Biohaven Ltd., Biohaven Pharmaceutical Holding Co Ltd., others
10,227,273 Shares BIOHAVEN LTD. COMMON SHARES, WITHOUT PAR VALUE UNDERWRITING AGREEMENTBiohaven Ltd. • October 5th, 2023 • Pharmaceutical preparations • New York
45,000,000 OF SHARES OF Vicarious Surgical Inc. Class A common stock, par value $0.0001 per share UNDERWRITING AGREEMENTVicarious Surgical Inc. • August 4th, 2023 • Orthopedic, prosthetic & surgical appliances & supplies • New York
The undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”) and Cowen and Company, LLC (“TD Cowen” and together with Morgan Stanley, the “Representatives”) propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Vicarious Surgical Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters named therein, including the Representatives (the “Underwriters”), of $45,000,000 of shares (the “Shares”) of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”).
3,775,000 Shares SI-BONE, INC. COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTSI-BONE, Inc. • May 8th, 2023 • Surgical & medical instruments & apparatus • New York
SI-BONE, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule II hereto (the “Underwriters”), for which BofA Securities, Inc., Morgan Stanley & Co. LLC and Jefferies LLC are acting as representatives (the “Representatives” or “you”), and the shareholder of the Company (the “Selling Shareholder”) named in Schedule I hereto proposes to sell to the several Underwriters, an aggregate of 3,775,000 shares of its common stock, par value $.0001 per share (the “Firm Shares”), of which 3,502,247 shares are to be issued and sold by the Company and 272,753 shares are to be sold by the Selling Shareholder.
l] Shares BIOHAVEN LTD. COMMON SHARES, WITHOUT PAR VALUE FORM OF UNDERWRITING AGREEMENTBiohaven Ltd. • October 18th, 2022 • Pharmaceutical preparations • New York
ALPINE IMMUNE SCIENCES, INC. 13,606,000 SHARES OF COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTAlpine Immune Sciences, Inc. • September 21st, 2022 • Pharmaceutical preparations • New York
3,250,000 SHARES TRANSMEDICS GROUP, INC. COMMON STOCK, NO PAR VALUE PER SHARE UNDERWRITING AGREEMENT August 4, 2022TransMedics Group, Inc. • August 8th, 2022 • Electromedical & electrotherapeutic apparatus • New York
] Shares CINCOR PHARMA, INC. COMMON STOCK, $0.00001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTCinCor Pharma, Inc. • January 3rd, 2022 • Pharmaceutical preparations • New York
As Representatives of the several Underwriters listed in Schedule I to the Underwriting Agreement referred to below Ladies and Gentlemen:Vigil Neuroscience, Inc. • January 3rd, 2022 • Biological products, (no disgnostic substances) • New York
4,000,000 Shares REPARE THERAPEUTICS INC. COMMON SHARES (NO PAR VALUE) UNDERWRITING AGREEMENTRepare Therapeutics Inc. • November 1st, 2021 • Pharmaceutical preparations • New York
•] Shares XILIO THERAPEUTICS, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTXilio Therapeutics, Inc. • October 18th, 2021 • Pharmaceutical preparations • New York
The undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”), Cowen and Company, LLC (“Cowen”) and Guggenheim Securities, LLC (together with Morgan Stanley and Cowen, the “Representatives”) propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Xilio Therapeutics, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including the Representatives (the “Underwriters”), of shares (the “Shares”) of the common stock, $0.0001 par value per share, of the Company (the “Common Stock”).
11,650,000 Shares IVERIC BIO, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTIVERIC Bio, Inc. • July 14th, 2021 • Pharmaceutical preparations • New York
3,100,000 Shares ZENTALIS PHARMACEUTICALS, INC. COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTZentalis Pharmaceuticals, Inc. • July 1st, 2021 • Pharmaceutical preparations • New York
The undersigned understands that Morgan Stanley & Co. LLC, Jefferies LLC and SVB Leerink LLC (collectively, the “Representatives”) propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Zentalis Pharmaceuticals, Inc., a Delaware corporation(the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including the Representatives (the “Underwriters”), of shares of the common stock, par value $0.001 per share, of the Company (the “Common Stock”).
11,765,000 Shares CHIMERIX, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTChimerix Inc • January 21st, 2021 • Pharmaceutical preparations • New York
4,000,000 Shares FULCRUM THERAPEUTICS, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTFulcrum Therapeutics, Inc. • January 20th, 2021 • Pharmaceutical preparations • New York
●] Shares DATTO HOLDING CORP. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTDatto Holding Corp. • October 14th, 2020 • Services-prepackaged software • New York
Shares GRAIL, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTGrail, Inc. • September 17th, 2020 • Services-medical laboratories • New York
c/o Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 c/o Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 c/o BofA Securities, Inc. One Bryant Park New York, New York 10036 c/o Cowen and Company, LLC 599 Lexington Avenue, 25th Floor New York, New York 10022 c/o Evercore Group L.L.C. 55 East 52nd Street New York, New York 10055
4,166,666 Shares NATERA, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTNatera, Inc. • September 11th, 2020 • Services-medical laboratories • New York
Natera, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives,” “you,” “your”), an aggregate of 4,166,666 shares of its common stock, par value $0.0001 per share (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters not more than an additional 624,999 shares of its common stock, par value $0.0001 per share (the “Additional Shares”) if and to the extent that the Representatives shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The shares of common stock, par value $0.0001 per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are hereinaf
1,860,000 Shares GREENPOWER MOTOR COMPANY INC. COMMON SHARES (WITHOUT PAR VALUE) UNDERWRITING AGREEMENTGREENPOWER MOTOR Co INC. • September 2nd, 2020 • Truck & bus bodies • New York
Shares GREENPOWER MOTOR COMPANY INC. COMMON SHARES (WITHOUT PAR VALUE) UNDERWRITING AGREEMENTGREENPOWER MOTOR Co INC. • August 25th, 2020 • Truck & bus bodies • New York
8,000,000 Shares REPAY HOLDINGS CORPORATION CLASS A COMMON STOCK (PAR VALUE $0.0001) UNDERWRITING AGREEMENTRepay Holdings Corp • June 2nd, 2020 • Services-business services, nec • New York
11,000,000 Shares AKEBIA THERAPEUTICS, INC. COMMON STOCK, PAR VALUE $0.00001 PER SHARE UNDERWRITING AGREEMENTAkebia Therapeutics, Inc. • May 12th, 2020 • Pharmaceutical preparations • New York
•] Shares IMARA INC. COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTIMARA Inc. • March 3rd, 2020 • Pharmaceutical preparations • New York
6,976,745 Shares BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. COMMON SHARES, WITHOUT PAR VALUE UNDERWRITING AGREEMENTBiohaven Pharmaceutical Holding Co Ltd. • June 21st, 2019 • Pharmaceutical preparations • New York
●] Shares BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. COMMON SHARES, WITHOUT PAR VALUE UNDERWRITING AGREEMENTBiohaven Pharmaceutical Holding Co Ltd. • December 10th, 2018 • Pharmaceutical preparations • New York
Shares VERITONE, INC. COMMON STOCK PAR VALUE $0.001 PER SHARE FORM OF UNDERWRITING AGREEMENTVeritone, Inc. • November 15th, 2017 • Services-computer processing & data preparation • New York
●] Shares BANDWIDTH INC. CLASS A COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTBandwidth Inc. • October 23rd, 2017 • Services-prepackaged software • New York
Shares FORESCOUT TECHNOLOGIES, INC. COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTForescout Technologies, Inc • October 16th, 2017 • Computer peripheral equipment, nec • New York
The undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”), as representative of the several underwriters, proposes to enter into an underwriting agreement (the “Underwriting Agreement”) with ForeScout Technologies, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several underwriters, including Morgan Stanley (the “Underwriters”), of shares (the “Shares”) of the common stock, $0.001 par value per share, of the Company (“Common Stock”).
10,000,000 Shares CHEGG, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTChegg, Inc • August 4th, 2017 • Services-educational services • New York
c/o Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 c/o Merrill Lynch, Pierce, Fenner & Smith IncorporatedOne Bryant ParkNew York, New York 10036
●] Shares VIAMET PHARMACEUTICALS CORP. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTViamet Pharmaceuticals Holdings LLC • April 8th, 2016 • Pharmaceutical preparations • New York
This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.
—] Shares APPFOLIO, INC. CLASS A COMMON STOCK PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTAppfolio Inc • June 4th, 2015 • Services-prepackaged software • New York
AppFolio, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom Morgan Stanley & Co. LLC and Credit Suisse Securities (USA) LLC (together, the “Representatives”) are acting as Representatives, an aggregate of [●] shares of the Class A common stock, par value $0.0001 per share, of the Company (the “Firm Shares”).
5,250,000 Shares CEMPRA, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTCempra, Inc. • January 8th, 2015 • Pharmaceutical preparations • New York
3,650,000 Shares CHIMERIX, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTChimerix Inc • October 31st, 2014 • Pharmaceutical preparations • New York
CHIMERIX, INC., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), 3,650,000 shares of the Company’s common stock, par value $0.001 per share (the “Firm Shares”).
Morgan Stanley & Co. LLC Citigroup Global Markets Inc.Versartis, Inc. • March 10th, 2014 • Pharmaceutical preparations • New York
This letter is being delivered to you in connection with the offering by Versartis, Inc. (the “Company”) of shares of common stock, $0.0001 par value (the “Common Stock”), of the Company and the lock-up letter dated , 20 (the “Lock-up Letter”), executed by you in connection with such offering, and your request for a [waiver] [release] dated , 20 , with respect to shares of Common Stock (the “Shares”).
11,000,000 Shares Baltic Trading LimitedBaltic Trading LTD • November 18th, 2013 • Deep sea foreign transportation of freight • New York
·] Shares Baltic Trading LimitedBaltic Trading LTD • November 12th, 2013 • Deep sea foreign transportation of freight • New York
